Literature DB >> 6572973

Total synthesis of insulin-like growth factor I (somatomedin C).

C H Li, D Yamashiro, D Gospodarowicz, S L Kaplan, G Van Vliet.   

Abstract

Human insulin-like growth factor I (somatomedin C) with 70 amino acid residues and three disulfide bridges has been synthesized by the solid-phase method. The synthetic product behaves as a pure polypeptide in paper electrophoresis, isoelectric focusing, and high-performance liquid chromatography, Its elution behavior in Sephadex G-50, isoelectric point, amino acid composition, and growth-stimulating activity in bovine adrenal cortical cells or granulosa cells are comparable to those reported for the natural product. In radioimmunoassay, the synthetic product is indistinguishable from the natural hormone when either synthetic or natural product is used as the labeled ligand.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6572973      PMCID: PMC393789          DOI: 10.1073/pnas.80.8.2216

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay.

Authors:  R W Furlanetto; L E Underwood; J J Van Wyk; A J D'Ercole
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

2.  Growth-hormone dependence of non-suppressible insulin-like activity (NSILA) and of NSILA-carrier protein in rats.

Authors:  U Kaufmann; J Zapf; E R Froesch
Journal:  Acta Endocrinol (Copenh)       Date:  1978-04

3.  Primary structure of human insulin-like growth factor II.

Authors:  E Rinderknecht; R E Humbel
Journal:  FEBS Lett       Date:  1978-05-15       Impact factor: 4.124

4.  Use of cyclopentyl ester protection for aspartic acid to reduce base catalyzed succinimide formation in solid-phase peptide synthesis.

Authors:  J Blake
Journal:  Int J Pept Protein Res       Date:  1979-04

5.  Evidence from radioligand assays that somatomedin-C and insulin-like growth factor-I are similar to each other and different from other somatomedins.

Authors:  J J Van Wyk; M E Svoboda; L E Underwood
Journal:  J Clin Endocrinol Metab       Date:  1980-01       Impact factor: 5.958

6.  Interaction of somatomedin-C with an antibody directed against the synthetic C-peptide region of insulin-like growth factor-I.

Authors:  R L Hintz; F Liu; L B Marshall; D Chang
Journal:  J Clin Endocrinol Metab       Date:  1980-02       Impact factor: 5.958

7.  Control of bovine adrenal cortical cell proliferation by fibroblast growth factor. Lack of effect of epidermal growth factor.

Authors:  D Gospodarowicz; C R Ill; P J Hornsby; G N Gill
Journal:  Endocrinology       Date:  1977-04       Impact factor: 4.736

Review 8.  Hormone families: pancreatic hormones and homologous growth factors.

Authors:  T L Blundell; R E Humbel
Journal:  Nature       Date:  1980-10-30       Impact factor: 49.962

9.  Purification of somatomedin-C from human plasma: chemical and biological properties, partial sequence analysis, and relationship to other somatomedins.

Authors:  M E Svoboda; J J Van Wyk; D G Klapper; R E Fellows; F E Grissom; R J Schlueter
Journal:  Biochemistry       Date:  1980-02-19       Impact factor: 3.162

10.  The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin.

Authors:  E Rinderknecht; R E Humbel
Journal:  J Biol Chem       Date:  1978-04-25       Impact factor: 5.157

View more
  7 in total

1.  Chemical synthesis of a gene for somatomedin C.

Authors:  B S Sproat; M J Gait
Journal:  Nucleic Acids Res       Date:  1985-04-25       Impact factor: 16.971

2.  Synthetic somatomedin C: comparison with natural hormone isolated from human plasma.

Authors:  J J Van Wyk; W E Russell; C H Li
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

Review 3.  Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations.

Authors:  R G Thorne; W H Frey
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

4.  Improved clonal and nonclonal growth of human, rat and bovine adrenocortical cells in culture.

Authors:  J M McAllister; P J Hornsby
Journal:  In Vitro Cell Dev Biol       Date:  1987-10

5.  Immunodetection of Insulin-Like Growth Factor I (IGF-l) in Normal and Pathological Adrenocortical Tissue.

Authors:  Samir Faical; Rui M. B. Maciel; Vania Nose-Alberti; Marivania C. Santos; Claudio E. Kater
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

6.  IGF-1/IGFBP-1 increases blastocyst formation and total blastocyst cell number in mouse embryo culture and facilitates the establishment of a stem-cell line.

Authors:  Ta-Chin Lin; Jui-Mei Yen; Kun-Bing Gong; Teng-Tsao Hsu; Lih-Ren Chen
Journal:  BMC Cell Biol       Date:  2003-09-19       Impact factor: 4.241

7.  Mechanistic Target of Rapamycin Complex 1 Signaling Links Hypoxia to Increased IGFBP-1 Phosphorylation in Primary Human Decidualized Endometrial Stromal Cells.

Authors:  Pinki Nandi; Chloe E Jang; Kyle Biggar; Chidambra D Halari; Thomas Jansson; Madhulika B Gupta
Journal:  Biomolecules       Date:  2021-09-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.